Results 91 to 100 of about 4,819 (199)

Topiramate plus citalopram in the treatment of Compulsive-Impulsive Sexual Behaviors [PDF]

, 2006
Compulsive-Impulsive Sexual Behaviors (C-ISBs) include repetitive sexual acts and compulsive sexual thoughts which occur so frequently and with such intensity that they interfere with sexual intimacy and interpersonal and occupational functioning and ...
D. Marazziti, B. Dell'Osso
core   +1 more source

Naltrexone Removal from Aqueous Media by Multi-Walled Carbon Nanotubes [PDF]

, 2016
Background: Extensive researches with different techniques are being carried out for removal of pharmaceuticals from aqueous media. The aim of this study was to use multi-walled carbon nanotubes (MWCNTs) to remove naltrexone as a pollutant of the aquatic
Ahmadi, Roushan, Ansari, Mehdi, Kazemipour, Maryam   +2 more
core  

Critical Review Report: p-Fluoro-butyrylfentanyl [PDF]

Substance identification p-Fluoro-butyrylfentanyl (IUPAC name: N-(4-fluorophenyl)-N-[1-(2-phenylethyl)piperidin-4- yl]butanamide) is a synthetic analog of the opioid analgesic fentanyl.
Brandt, SD
core  

A multicenter, primary care-based, open-label study to identify behaviors related to prescription opioid misuse, abuse, and diversion in opioid-experienced patients with chronic moderate-to-severe pain

Journal of Pain Research, 2015
Beatrice Setnik,1 Carl L Roland,1 Kenneth W Sommerville,1,2 Glenn C Pixton,1 Robert Berke,3,4 Anne Calkins,5 Veeraindar Goli1,2 1Pfizer Inc, 2Duke University Medical Center, Durham, NC, 3Family Health Medical Services PLLC, Mayville, NY, 4Department of ...
Setnik B, Rol, CL, Sommerville KW, Pixton GC, Berke R, Calkins A, Goli V   +7 more
doaj  

Expanding the spectrum of impulse control disorders in Parkinson's disease: the phenomenology of sweet craving [PDF]

, 2013
Thesis (M.A.)--Boston UniversityBackground: The recognized spectrum of impulse control disorders in Parkinson’s disease (PD) includes pathologic gambling, hypersexuality, compulsive buying, and binge eating, and is commonly related to exposure to ...
Brown, Caitlin Harrington
core   +1 more source

Experience with an extended-release opioid formulation designed to reduce abuse liability in a community-based pain management clinic

International Journal of General Medicine, 2011
Daniel Rubino Pain Center of Devon, Devon, PA, USA Context: With the growing public health concern over rising rates of opioid abuse, physicians have a responsibility to incorporate safeguards into their practice to minimize the potential for opioid ...
Rubino D
doaj  

A multicenter, primary-care-based, open-label study to assess the success of converting opioid-experienced patients with chronic moderate-to-severe pain to morphine sulfate and naltrexone hydrochloride extended-release capsules using a standardized conversion guide

Journal of Pain Research, 2015
Beatrice Setnik,1 Carl L Roland,1 Kenneth W Sommerville,1,2 Glenn C Pixton,1 Robert Berke,3,4 Anne Calkins,5 Veeraindar Goli1,2 1Pfizer Inc, 2Duke University Medical Center, Durham, NC, USA; 3Family Health Medical Services PLLC, Mayville, 4Department of ...
Setnik B, Rol, CL, Sommerville KW, Pixton GC, Berke R, Calkins A, Goli V   +7 more
doaj  

MT-7716, a potent NOP receptor agonist, preferentially reduces ethanol seeking and reinforcement in post-dependent rats

, 2015
Dysregulation of the nociceptin (N/OFQ) system has been implicated in alcohol abuse and alcoholism, and growing evidence suggests that targeting this system may be beneficial for treating alcoholism.
Aujla, Ayanwuyi, Braconi, Bunzow, Ciccocioppo, Ciccocioppo, Ciccocioppo, Ciccocioppo, Ciccocioppo, Ciccocioppo, Cruz, Eckardt, Economidou, Economidou, Erb, Everitt, Funk, Gozzi, Hansson, Hansson, Kallupi, Le, Liu, Macey, Martin-Fardon, Martin-Fardon, Mollereau, Neal, Roberto, Roberts, Rodd, Silberman, Sommer, Teshima, Valdez, Weiss, Wise, Zhao, Zorrilla   +38 more
core   +1 more source

Treatment of drug addiction and psychopathology: a field study [PDF]

, 2010
[Abstract] Field study to assess the concurrence of the psychopathology of drug addiction, and to evaluate the efficacy of pharmacological treatment versus drug-free treatments for the psychopathology of drug addiction.
Fernández-Ríos, Luis, Isorna, Manuel, Souto-Gestal, Antonio   +2 more
core   +3 more sources

Does Misery Love Company? Evidence from pharmaceutical markets before and after the Orphan Drug Act [PDF]

With substantial fixed costs of drug development, more common conditions can support more products. If additional pharmaceutical products are beneficial, they will attract greater consumption and promote better health, e.g. greater longevity.
Frank R. Lichtenberg, Joel Waldfogel
core